Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2006-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2006-948308PMID 17177140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.

  2005cited by this paper
• Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.

  2005cited by this paper
• Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery.

  2005cited by this paper
• Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

  2005cited by this paper
• Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults.

  2005cited by this paper
• Clinical and Biochemical Characterization of Women with Polycystic Ovary Syndrome in North Rhine-Westphalia

  2005cited by this paper
• Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

  2005cited by this paper
• The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome

  2005cited by this paper
• Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats.

  2005cited by this paper
• Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study.

  2004cited by this paper
• Calcitriol Improves Streptozotocin-induced Diabetes and Recovers Bone Mineral Density in Diabetic Rats

  2004cited by this paper
• Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.

  2004cited by this paper
• Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus.

  2003cited by this paper
• THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS

  2003cited by this paper
• Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome.

  2003cited by this paper
• Circulating ghrelin concentrations in the polycystic ovary syndrome.

  2003cited by this paper
• Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.

  2003cited by this paper
• Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

  2003cited by this paper
• Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

  2003cited by this paper
• Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

  2002cited by this paper
• Adiposity and fat distribution outcome measures: assessment and clinical implications.

  2002cited by this paper
• Regulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and Implications

  2002cited by this paper
• Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

  2002cited by this paper
• High prevalence of hypovitaminosis D in female type 2 diabetic population.

  2001cited by this paper
• Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.

  2001cited by this paper
• Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

  2000cited by this paper
• Regulation of adiposity by dietary calcium

  2000cited by this paper
• Decreased bioavailability of vitamin D in obesity.

  2000cited by this paper
• Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

  1999cited by this paper
• Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

  1999cited by this paper
• Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

  1999cited by this paper
• Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?

  1996cited by this paper
• 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

  1996cited by this paper
• Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo.

  1995cited by this paper
• A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

  1991cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• The relationship of insulin to sex hormone-binding globulin: role of adiposity.

  1989cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.

  1985cited by this paper
• Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle.

  1985cited by this paper
• Vitamin D status and bone histomorphometry in gross obesity.

  1981cited by this paper
• Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex

  1977cited by this paper
• The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.

  1956cited by this paper

• A meta-analysis of the literature evaluating the impact of vitamin D on female fertility and ovarian reserve function

  2026cites this paper
• Metaanálisis de la literatura que evalúa el impacto de la vitamina D en la fertilidad femenina y la función de reserva ovárica

  2026cites this paper
• The impact of polycystic ovary syndrome on some sex hormones, HbA1C and vitamin D3: a case-control study

  2025cites this paper
• Consequences of vitamin D deficiency or overdosage on follicular development and steroidogenesis in Normo and hypo calcemic mouse models

  2025cites this paper
• Deciphering polycystic ovary syndrome: A brief overview from metabolic drivers to genetic and fetal origins.

  2025cites this paper
• Micronutrients and polycystic ovary syndrome in the IEU OpenGWAS project: a two-Sample unidirectional Mendelian randomization analysis

  2025cites this paper
• The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review

  2025cites this paper
• Preliminary Screening Value of 25-Hydroxyvitamin D Levels in Patients with Polycystic Ovary Syndrome for Metabolic Syndrome

  2025cites this paper
• Effects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial

  2025cites this paper
• A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D

  2024cites this paper
• Association of Vitamin D with Perfluorinated Alkyl Acids in Women with and without Non-Obese Polycystic Ovary Syndrome

  2024cites this paper
• The Impact of Vitamin D Receptor Gene Polymorphisms (FokI, ApaI, TaqI) in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome

  2024cites this paper
• Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome

  2024cites this paper
• Role of vitamin D and leptin levels in PCOS in young women: A family medicine perspective

  2024cites this paper
• Role of VDR gene polymorphisms and vitamin D levels in normal and overweight patients with PCOS.

  2024cites this paper
• Is there any association between vitamin D status and PCOS disease?

  2024cites this paper
• Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis

  2024cites this paper
• Association of vitamin D deficiency with demographic, metabolic and sex hormone levels in polycystic ovarian syndrome

  2024cites this paper
• Vitamin D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet

  2024cites this paper
• Women's fertility and vitamin D: Could hypovitaminosis D biomarkers correlate with the disease, and explain the unexplained female factor infertility?

  2024cites this paper
• Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study

  2024cites this paper
• Effect of vitamin supplementation on polycystic ovary syndrome and key pathways implicated in its development: A Mendelian randomization study

  2023cites this paper
• The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome

  2023cites this paper
• Role of Vitamin D in the treatment of polycystic ovarian syndrome: A systematic review

  2023cites this paper
• Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome

  2023cites this paper
• Study the Effect of the Different Levels of Vitamin D3 in Women with Polycystic Ovary Syndrome and Infertility Women

  2023cites this paper
• Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study

  2023cites this paper
• CORRELATION OF VITAMIN D WITH AMH IN PCOS FEMALES

  2023cites this paper
• Association of polychlorinated biphenyls with vitamin D in female subjects.

  2023cites this paper
• Insulin Resistance and Bone Metabolism Markers in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study on Females from the Islamic University Medical Center

  2023cites this paper
• Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis

  2023cites this paper
• Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D

  2023cites this paper
• Vitamin D and polycystic ovary syndrome (PCOS): a review

  2023cites this paper
• Hypovitaminosis D in Painful Peripheral Neuropathy

  2023cites this paper
• The Effect of Vitamin D3 Supplemented with PhytoSolve on Genes Involved in Implantation in an NMRI Mice Model of Polycystic Ovary Syndrome: An Experimental Study

  2023cites this paper
• The relationship between the level of vitamin D, leptin and FGF23 in girls and young women with polycystic ovary syndrome

  2022cites this paper
• The Effect of Vitamin D Administration on Androgen Levels in Addition to Metformin Treatment in Adolescent Girls with Hyperandrogenism

  2022cites this paper
• Integration analysis of metabolome and transcriptome reveals the effect of exogenous supplementation with mixtures of vitamins ADE, zinc, and selenium on follicular growth and granulosa cells molecular metabolism in donkeys (Equus asinus)

  2022cites this paper
• Parameters for Calcium Metabolism in Women with Polycystic Ovary Syndrome Who Undergo Stimulation with Letrozole: A Prospective Cohort Study

  2022cites this paper
• Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D

  2022cites this paper
• Evaluation of insulin resistance and vitamin D levels in patients with polycystic ovary syndrome

  2022cites this paper
• Accuracy of office hysteroscopy in the diagnosis of chronic endometritis

  2022cites this paper
• Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women.

  2022cites this paper
• Vitamin D metabolism in polycystic ovary syndrome (PCOS)

  2022cites this paper
• Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.

  2022cites this paper
• Effects of Vitamin D on Fertility, Pregnancy and Polycystic Ovary Syndrome—A Review

  2022cites this paper
• Are Phenotypes of PCOS and Vitamin D Levels Interlinked

  2022cites this paper
• Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites

  2022cites this paper
• Follicular fluid 25-hydroxyvitamin D levels determine fertility outcome in patients with polycystic ovary syndrome.

  2022cites this paper
• PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment

  2022cites this paper
• The Role of Vitamin D in Metabolic Syndrome in Polycystic Ovary Syndrome

  2022cites this paper
• Does vitamin D level associate with pregnancy outcomes in Chinese women undergoing in vitro fertilization/intracytoplasmic sperm injection‐embryo transfer? A retrospective cohort study

  2022cites this paper
• Dietary Magnesium Intake Level Modifies the Association Between Vitamin D and Insulin Resistance: A Large Cross-Sectional Analysis of American Adults

  2022cites this paper
• Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice

  2021cites this paper
• Correlation of Vitamin D Levels with Polycystic Ovary Syndrome: A Cross-sectional Study

  2021cites this paper
• Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome.

  2021cites this paper
• OVERVIEW OF VITAMIN D ROLE IN POLYCYSTIC OVARIAN SYNDROME

  2021influential citation
• PCOS and Depression: Common Links and Potential Targets

  2021cites this paper
• Suplementación de vitamina D en embarazadas y en mujeres con patologías ginecológicas

  2021cites this paper
• Vitamin D association with the renin angiotensin system in polycystic ovary syndrome.

  2021cites this paper
• Prevalence of hypovitaminosis D in COVID-19 patients in the intensive care unit

  2021cites this paper
• Polymorphisms of Vitamin D Receptor and the Effect on Metabolic and Endocrine Abnormalities in Polycystic Ovary Syndrome: A Review

  2021cites this paper
• Ovarian effects of vitamin D: a systematic review

  2021cites this paper
• Vitamin D Deficiency Is Inversely Associated with Homeostatic Model Assessment of Insulin Resistance

  2021cites this paper
• Vitamin D and Insulin Resistance in Polycystic Ovarian Syndrome and Congenital Adrenal Hyperplasia-a Commentary and Natural Expansion

  2021influential citation
• Association between vitamin D and glycaemic parameters in a multi-ethnic cohort of postmenopausal women with type 2 diabetes in Saudi Arabia

  2021cites this paper
• EVALUATION OF THE RELATIONSHIP BETWEEN D VITAMIN LEVEL IN COPD PATIENTS WITH ACUTE RESPIRATORY FAILURE

  2021cites this paper
• Research Progress on the Relationship between Vitamin D and Female Reproduction

  2021cites this paper
• Low Circulating Vitamin D in Intensive Care Unit–Admitted COVID-19 Patients as a Predictor of Negative Outcomes

  2021cites this paper
• The interplay of vitamin D and body mass index in acne patients vs. controls

  2021cites this paper
• Vitamin D Deficiency effects on Cardiovascular Parameters in Women with Polycystic Ovary Syndrome: a retrospective, cross-sectional study.

  2021cites this paper
• Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome

  2021cites this paper
• Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome

  2021cites this paper
• Prevention and Management of Gestational Diabetes Using Vitamin D Supplementation: An Overview and Appraisal of Clinical Trials

  2020cites this paper
• Effect of Vitamin D Supplementation on Ovulation among Women with PCO

  2020cites this paper
• Association of BsmI variant of vitamin D receptor gene with polycystic ovary syndrome: A case-control study

  2020cites this paper
• [Vitamin D and reproductive health].

  2020cites this paper
• The relationship between Vitamin D deficiency and polycystic ovary syndrome

  2020cites this paper
• Vitamin D and Polycystic Ovary Syndrome: a Narrative Review

  2020cites this paper
• Assessing the effect of MitoQ10 and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model

  2020cites this paper
• Maternal 25-hydroxyvitamin D correlates with weight gain and bone metabolism during pregnancy

  2020cites this paper
• Association of Vitamin D Status with Polycystic Ovary Syndrome in Relation to Insulin Resistance and Serum Total Testosterone

  2020cites this paper
• Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study

  2020cites this paper
• Serum vitamin D levels and ovarian reserve markers in secondary amenorrhea patients: Is there a link?

  2020cites this paper
• The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency

  2020cites this paper
• The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D

  2020cites this paper
• Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.

  2020cites this paper
• The determination of anti-mullerian hormone and vitamin D serum levels in polycystic ovary syndrome

  2020cites this paper
• Dietary and Physical Activity Behaviors in Women with Polycystic Ovary Syndrome per the New International Evidence-Based Guideline

  2019cites this paper
• Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial

  2019cites this paper
• Diabetic peripheral neuropathy: the potential role of vitamin D deficiency

  2019cites this paper
• Role of Vitamin D Supplementation Therapy on Ovulation and Insulin Resistance in Women with PCOS: A Randomized Controlled Trial

  2019cites this paper
• The effect of serum vitamin D levels in couples on embryo development and clinical outcomes.

  2019cites this paper
• Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS.

  2019cites this paper
• Vitamin D, reproductive disorders and assisted reproduction: evidences and perspectives

  2019cites this paper
• Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome

  2019cites this paper
• Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study

  2019cites this paper
• Insulin Resistance in Adults with Type 1 Diabetes is Associated with Lower Vitamin D Serum Concentration.

  2019cites this paper
• Associations between vitamin D levels and polycystic ovary syndrome phenotypes.

  2019cites this paper
• Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?

  2019cites this paper